Google DeepMind launched AlphaGenome, an AI tool designed to identify genetic drivers of disease.
The system analyses up to one million DNA letters at once to predict how mutations affect gene regulation.
AlphaGenome focuses on the non-coding genome, which controls when and where genes activate.
Researchers trained the model on large human and mouse genetics databases.
Scientists believe the tool could accelerate cancer research and rare disease diagnosis.
AlphaGenome may also support new gene therapies by helping design targeted DNA sequences.
Trending
- US Airline Cleared to Fly to Venezuela Today
- Alain St. Ange Wins Top Tourism Award
- California Women Win Big in ACC Tournament
- Public Storage HQ Moves Texas Expansion
- New Immunotherapy Drug Shows Remarkable Early Results in Advanced Prostate Cancer
- Middle East Conflict Escalates After Israeli Strikes in Iran
- Debt Drama Surrounding Essl19 Million Officially – Media Reports Up to 30 Million
- Trump Shuts Down Anthropic AI in Federal Agencies as Pentagon Dispute Grows
Google DeepMind Unveils AlphaGenome to Decode Genetic Causes of Disease
Andrew Rogers
Andrew Rogers is a freelance journalist based in Chicago, USA, with over 10 years of experience covering Politics, World Affairs, Business, Health, Technology, Finance, Lifestyle, and Culture. He graduated with a degree in Journalism from the University of Florida. Over the years, he has contributed to leading outlets such as The New York Times, CNN, and Reuters. Recognized for his sharp reporting and thoughtful analysis, Andrew delivers accurate and timely news that keeps readers updated on key national and global developments.
Add A Comment